All Type of News
Korean drugmakers issue signature campaign against low-priced drug incentive system
The Korea Pharmaceutical Manufacturer Association said on November 20 it delivered its petition letter to Chong Wa Dae in protest of the health ministry's plan to offer an incentive to hospitals who will purchase low-...
Low-priced incentive system to fatten hospitals
The new incentive system is likely to have patients and health insurance subscribers make undue payments to fatten the coffers of hospitals and doctors, according to market insiders.
Aimed at providing cheaper drug...
Green Cross seeking free supply of Peramir
Green Cross Corporation is considering offering an investigational antiviral drug Peramivir intravenous (IV) for the treatment of certain adult and pediatric patients with confirmed or suspected H1N1 influenza infecti...
Two big wholesalers seeking more share in Pusan
Geoyoung, a local leading wholesaler, is set to expand its share in Pusan under its strategic alliance with Chungsipja, while a leading wholesaler in Daegu is poised to get more pie in the region.
Industry watchers...
Korea Bone Bank selected as Asia’s promising enterprise
ePlanet Ventures, the world’s leading global venture capital firm headquartered in Silicon Valley, California, announced on November 20 that Korea Bone Bank was selected as one of the most promising corporations with ...
Wholesalers issue ultimatum to expand direct dealing
The Korea Association of Pharmaceutical Wholesaler says it delivered an official letter, asking several multinational companies to respond to their request for direct transaction by November 17.
These companies inc...
Healthcare providers seek to overhaul medical insurance fee system
The nation’s five healthcare organizations are proposing to establish a special committee to overall the current medical and pharmaceutical dispensing fee system.
These organizations consist of the Korean Pharmaceu...
Rising development costs make biosimilar market entry a difficult proposition
Biosimilar development is riddled with complexities, ranging from regulatory, to manufacturing to marketing, and is one of the most expensive propositions in the pharmaceutical industry, according to market experts.
...
Key success factors in emerging biosimilar markets
Despite the fact that the biosimilars market presents a multitude of opportunities, biosimilar development is a risk-fraught activity that demands significant resources in R&D, manufacturing expertise, regulatory know...
Indiscriminate use of antiviral medications yielding drug-resistant strains of H1N1 virus
Indiscriminate use of antiviral medications to prevent and treat influenza could ease the way for drug-resistant strains of the H1N1 virus, or swine flu, to emerge, a lawmaker warns – making the fight against a pandem...
